Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

David Wayne Ussery

◆ ARA Academy High Impact

Professor of Genetics

Also affiliated: Kunming University of Science and Technology (2018); Universitat de Miguel Hernández d'Elx (2012); Oklahoma State University (2025–2026); Universidade Federal do Rio de Janeiro (2015); Oak Ridge National Laboratory (2011–2017); Siriraj Hospital (2018); University of New Mexico (1984); Copenhagen Business School (2006); University of Oslo (2007–2011); Washington University in St. Louis (2009); Mahidol University (2018); University of South Florida (1994); University of Arkansas Medical Center (2025); John Radcliffe Hospital (1994–1997); Moffitt Cancer Center (1994); University of Oxford (1994–1997); Molecular Microbiology and Genomics Consultants (Germany) (2017–2018); University of Cincinnati (1991); University of Tennessee at Knoxville (2014–2015); University of California, Davis (2009); Texas A&M University (1992–1996); Technical University of Denmark (1999–2016)

62 h-index 371 pubs 27,019 cited

  • Genome, Bacterial
  • Humans
  • Phylogeny
  • Genomics
  • Sequence Analysis, DNA
  • Base Sequence
  • Molecular Sequence Data
  • DNA, Bacterial
  • Bacterial Proteins
  • Computational Biology
  • Escherichia coli
  • Animals
  • Genes, Bacterial
  • Nucleic Acid Conformation
  • Bacteria

Biography and Research Information

OverviewAI-generated summary

David Ussery's research focuses on the bioinformatic analysis of bacterial genomes, a field he has engaged with since 1995. He previously led the Arkansas Center for Genomic Epidemiology and Medicine at the University of Arkansas, from 2016 to 2025. During his tenure, his group was responsible for sequencing the first reported COVID-19 Omicron variant in Arkansas in December 2021. His work has also involved developing methodologies for pathogen monitoring in wastewater.

Ussery has a history of teaching graduate courses in bioinformatics and has conducted numerous international workshops on comparative genomics. His research network includes collaborators in the United Kingdom, Denmark, Norway, Germany, and Belgium. He has published extensively, with over 368 publications and a citation count exceeding 26,000, and holds an h-index of 62. His work has been recognized with designations such as an ARA Academy member and a highly cited researcher.

Metrics

  • h-index: 62
  • Publications: 371
  • Citations: 27,019

Positions

  • Professor of Genomics 2025–present
    Oklahoma State University Department of Physiological Sciences, College of Veterinary Medicine ORCID
  • Professor of Genetics publications 2016–2026
    University of Arkansas for Medical Sciences Institutional directory
  • Oklahoma State University publications 2025–2026
    ORCID
  • professor 2016–2025
    University of Arkansas for Medical Sciences Department of Biomedical Informatics ORCID
  • Comparative Genomics group leader 2013–2016
    Oak Ridge National Laboratory Biosciences Division ORCID
  • Comparative Genomics group leader 1997–2014
    Technical University of Denmark Center for Biological Sequence Analysis CBS ORCID

Selected Publications

  • A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence (2026)
    Oncotarget DOI OpenAlex
  • A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026)
  • A Tracts of Homozygosity Approach Identifies Methylation-Regulated <i>CSMD1</i> Expression Targets in Non–Small Cell Lung Cancers Related to Smoking Behavior (2025)
  • Using machine learning to predict the severity of salmonella infection (2025)
  • Abstract 1923: A tract of homozygosity analysis reveals methylation-driven <i>CSMD1</i> expression in non-small cell lung cancers (2025)
  • A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025)
    2 citations DOI OpenAlex
  • Investigating the origins of the mutational signatures in cancer (2025)
    Nucleic Acids Research 23 citations DOI OpenAlex
  • C.S. Lewis Philosopher — Who Changed My Life. Notes on the Margins of The Magician's Twin (2024)
  • Review 1: "Emergence of Transmissible SARS-CoV-2 Variants with Decreased Sensitivity to Antivirals in Immunocompromised Patients with Persistent Infections" (2024)
  • Reviews of "Emergence of Transmissible SARS-CoV-2 Variants with Decreased Sensitivity to Antivirals in Immunocompromised Patients with Persistent Infections" (2024)
  • DNA structural features and variability of complete MHC locus sequences (2024)
    Frontiers in Bioinformatics 7 citations DOI OpenAlex
  • Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus <i>Candida</i> adjuvant alone in treating cervical intraepithelial neoplasia 2/3. (2024)
    1 citation DOI OpenAlex
  • Genomic surveillance of SARS-CoV-2 using long-range PCR primers (2024)
    Frontiers in Microbiology 10 citations DOI OpenAlex
  • Review of: "Can the definitions of SARS-Cov-2 and Covid-19 stand up to epistemological scrutiny?" (2023)
  • Review of: "Evolution of new variants of SARS-CoV-2 during the pandemic: mutation-limited or selection-limited?" (2023)

View all publications on OpenAlex →

ARA Academy 2016 ARA Scholar

Collaboration Network

241 Collaborators 76 Institutions 19 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics